Lipogenesis partially accounts for the NAFLD disease of T2D, and proved to be fully responsive to insulin in T2D animal models and patients, in face of resistance to insulin in the glycemic context [57]. This evidence concerns the gene INS and metabolic dysfunction-associated steatotic liver disease.